SEC Form 4 · accession 0001645627-18-000063
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Oct 1, 2018
Accepted (ET)
Oct 5, 2018 · 5:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 1, 2018 | P | 1,000 | $0.051 | A | 25,979,898 | D | |
| Common Stock | Oct 1, 2018 | P | 2,000 | $0.0486 | A | 25,981,898 | D | |
| Common Stock | Oct 1, 2018 | P | 1,000 | $0.0496 | A | 25,982,898 | D | |
| Common Stock | Oct 1, 2018 | P | 1,000 | $0.0497 | A | 25,983,898 | D | |
| Common Stock | Oct 1, 2018 | P | 1,000 | $0.0484 | A | 25,984,898 | D | |
| Common Stock | Oct 1, 2018 | P | 1,000 | $0.0484 | A | 25,985,898 | D | |
| Common Stock | Oct 1, 2018 | P | 1,000 | $0.0476 | A | 25,986,898 | D | |
| Common Stock | Oct 3, 2018 | P | 1,000 | $0.0576 | A | 25,987,898 | D | |
| Common Stock | Oct 3, 2018 | P | 2,000 | $0.0588 | A | 25,989,898 | D | |
| Common Stock | Oct 3, 2018 | P | 1,000 | $0.0586 | A | 25,990,898 | D | |
| Common Stock | Oct 3, 2018 | P | 1,000 | $0.0586 | A | 25,991,898 | D | |
| Common Stock | Oct 4, 2018 | P | 1,000 | $0.0568 | A | 25,992,898 | D | |
| Common Stock | Oct 4, 2018 | P | 1,000 | $0.057 | A | 25,993,898 | D |
Table II — derivative securities
No Table II lines on this filing.